arrow-left arrow-right Arrow-Left

Macular Centre

Treatment for Macular Degeneration

The Valeda Light delivery system is the first approved treatment for Dry Age-Related Macular Degeneration using photobiomodulation.

 

Valeda uses a multi-wavelength approach to stimulate critical targets of cellular function, leading to improved energy production within the mitochondria.


 

What is Macular Degeneration?

The macular is the central and most important part of our retinas. It is responsible for our central vision which we use every moment of everyday of our waking lives. Our peripheral vision is important too but it is the central vision that we rely on to identify everyday objects, revealing the details of nature, looking at the letters on the vision chart, and recognising faces. Essentially is it the part that gives us our high-definition vision.

Our retinas are one of the most used parts of the body. The macular region works the hardest throughout the day. When light enters the eye, it is absorbed by photoreceptors in the retina which then triggers a complex sequence of chemical reactions. These chemical reactions are then passed along to the visual areas of the brain to be translated into ‘vision’. These chemical reactions expend a lot of energy and require a lot of maintenance.

We rely on the same retina and macular for our whole lifetimes. Unlike the rest of our body systems, we are unable to regenerate the cells of the retina. With the eyes being in constant use from the moment we open our eyes to the time we close them for sleep, it is not surprising that the ageing process affects the retina first and in particular, the macular. 

 

Signs of Macular Degeneration

As there are no symptoms in the initial stages of macular degeneration, it is important to have regular eye exams to identify early disease. Optical coherence tomography and fundus imaging are vital assessment techniques to detect and monitor signs of physical macular changes.

First signs of macular ageing include the development of drusen and retinal pigment changes.  Normally the waste materials from the photoreceptor chemical reactions are removed from the retina. Ageing of the retina causes this process to slow and the waste products accumulate between the retinal pigment epithelium and the choroid to form yellow spots called drusen.

In ‘Dry’ macular degeneration (also called ‘atrophic’) the drusen builds up and accumulate to cause damage to the retina. As the degeneration advances, geographic atrophy develops leading to blind spots in the centre of vision. This is the most common form of macular degeneration, often occurring gradually, and is less severe.

 
Photo of the retina showing drusen at the macular. These are ‘soft’ drusen which appear as yellow spots with poorly defined edges. Soft drusen is more likely to join together and form Geographic Atrophy.
 
This is an OCT image of the same eye showing the soft drusen as dome shaped elevations. They are filled with waste products that have failed to clear away.

 

‘Wet’ macular degeneration (also called ‘exudative or neovascular’) can occur more suddenly and vision can be impaired rapidly. The ‘Wet’ change happens when there is a breakdown of a layer of the retina called Bruch’s membrane, causing blood vessels to breakthrough into the retina at the macular. These abnormal vessels can break and leak fluid causing the macular to become distorted. This process generally results in rapid loss of central vision unless detected early and treated early. 

It is therefore important to self-monitor from time to time to check for early signs of ‘Wet’ changes. The Amsler chart is something you can use to detect early subtle effects to vision. Click here to access the Amsler chart.

 

Amsler Chart
Results showing blindspots and distortion at the macular

Visual Effects of Macular Degeneration

Vision is not affected in the initial stages but as it progresses, one may start to notice changes to their central vision:

  • Blurred central vision
    • Words on the page may become blurred and harder to recognise. More difficulty may be experienced in recognising faces of people you know.
  • Distorted central vision
    • Straight lines may appear wavy. Everyday objects like door and window frames may start to appear bent or curved.
  • Loss of contrast and colour perception
    • More difficulty may be noticed in lower light levels and colour distinction becomes more difficult.
  • Slower recovery of vision from exposure to bright light
    • More difficulty may be experienced adapting vision when going into lower lighting situation. Dark adaptation may take longer when switching lights off.

What treatments are available?

Wet Macular Degeneration – requires urgent treatment by a retinal specialist ophthalmologist or specialist retinal clinic. Historically, Wet AMD was treated with laser photocoagulation or photodynamic therapy (PDT). The current recommended treatment is anti-vascular endothelial growth factor (Anti-VEGF) injections. The drugs stop the new abnormal blood vessels from forming. The injections are repeated on a regular basis until the neovascularisation process is stabilised.

Dry Macular Degeneration – up until recently, there has been no clinically proven treatment available. The treatment has been based upon improving diet, taking macular supplements and smoking cessation programmes.

Exciting news is that there is now photobiomodulation treatment available for dry macular degeneration. The treatment is provided by a device called the Valeda Light Delivery System by Lumithera…

Learn more about Valeda Light Delivery System…